The protective function of oxymatrine on renal interstitial fibrosis in rats

Ganglian Yao,Ning Ning,Dengfeng Gao,Baosong Gui
DOI: https://doi.org/10.3969/j.issn.1671-8259.2006.03.014
2006-01-01
Abstract:Objective: To investigate the protective function of oxymatrine on the renal intestitial fibrosis in rats. Methods: Forty male Sprague Dawley rats were randomly divided into 5 groups: sham group, model group, Lotensin group, large-dose oxymatrine group, and small-dose oxymatrine group. The models were established by unilateral ureteral obstruction(UUO) of the left side. On the 14th day after operation, the obstructed kidney was taken out. Then, HE, Massion, and immunohistochemistry staining of transforming growth factor-β1 (TG F-β1), or smooth muscle acting (α-SMA) and collagen III were conducted. After that, semiquantitative analysis was performed. Results: After oxymatrine, treatment, the expressions of α-SMA, TGF-β1 and Col III of the obstructed kidney in the treatment group were significantly lower than those in the model group (P<0.01); the expressions in the large-dose oxymatrine group were lower than those in the lotensin group; while there were no significant difference between the large-dose and small-dose oxymatrine groups (P > 0.05). Conclusion: Oxymatrine may reduce the expression of cytokines such as TGF- β1, then the activation of cell producing ECM and then the sendimentation of ECM, thus preventing renal interstitial fibrosis.
What problem does this paper attempt to address?